Gerard R. Ridgway

Gerard R. Ridgway

Auto-generated profile, based on publicly available information

Gerard R. Ridgway

Oxford Brain Diagnostics Ltd Oxford UK

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2014 in NeuroImage
Verified
Journal Article
Open access
AWAnderson Winkler
Anderson Winkler
GRGerard R. Ridgway
Gerard R. Ridgway
MWMatthew A. Webster
Matthew A. Webster
SSStephen M. Smith
Stephen M. Smith
TNThomas E. Nichols
Thomas E. Nichols
Permutation methods can provide exact control of false positives and allow the use of non-standard statistics, making only weak assumptions about the data. With the availability of fast and inexpensive computing, their main limitation would be some lack of flexibility to work with arbitrary experimental designs. In this paper we report on results on approximate permutation methods that are more flexible with respect to the experimental design and nuisance variables, and conduct detailed simulations to identify the best method for settings that are typical for imaging research scenarios. We present a generic framework for permutation inference for complex general linear models (GLMS) when the errors are exchangeable and/or have a symmetric distribution, and show that, even in the presence of nuisance effects, these permutation inferences are powerful while providing excellent control of false positives in a wide range of common and relevant imaging research scenarios. We also demonstrate how the inference on GLM parameters, originally intended for independent data, can be used in certain special but useful cases in which independence is violated. Detailed examples of common neuroimaging applications are provided, as well as a complete algorithm - the "randomise" algorithm - for permutation inference with the GLM.

1 June 2010 in Computer Methods and Programs in Biomedicine
Verified
Journal Article
Closed access
MMMarc Modat
Marc Modat
GRGerard R. Ridgway
Gerard R. Ridgway
ZTZeike A. Taylor
Zeike A. Taylor
MLManja Lehmann
Manja Lehmann
JBJosephine Barnes
Josephine Barnes
SOSébastien Ourselin
Sébastien Ourselin

1 February 2012 in NeuroImage
Verified
Journal Article
Closed access
DRDavid Raffelt
David Raffelt
JTJ.-Donald Tournier
J.-Donald Tournier
SRStephen Rose
Stephen Rose
GRGerard R. Ridgway
Gerard R. Ridgway
RHRobert Henderson
Robert Henderson
ACAlan Connelly
Alan Connelly

1 January 2017 in NeuroImage
Verified
Journal Article
Open access
DRDavid A. Raffelt
David A. Raffelt
JTJ.-Donald Tournier
J.-Donald Tournier
RSRobert Smith
Robert Smith
DVDavid N. Vaughan
David N. Vaughan
GJGraeme Jackson
Graeme Jackson
ACAlan Connelly
Alan Connelly
Voxel-based analysis of diffusion MRI data is increasingly popular. However, most white matter voxels contain contributions from multiple fibre populations (often referred to as crossing fibres), and therefore voxel-averaged quantitative measures (e.g. fractional anisotropy) are not fibre-specific and have poor interpretability. Using higher-order diffusion models, parameters related to fibre density can be extracted for individual fibre populations within each voxel ('fixels'), and recent advances in statistics enable the multi-subject analysis of such data. However, investigating within-voxel microscopic fibre density alone does not account for macroscopic differences in the white matter morphology (e.g. the calibre of a fibre bundle). In this work, we introduce a novel method to investigate the latter, which we call fixel-based morphometry (FBM). To obtain a more complete measure related to the total number of white matter axons, information from both within-voxel microscopic fibre density and macroscopic morphology must be combined. We therefore present the FBM method as an integral piece within a comprehensive fixel-based analysis framework to investigate measures of fibre density, fibre-bundle morphology (cross-section), and a combined measure of fibre density and cross-section. We performed simulations to demonstrate the proposed measures using various transformations of a numerical fibre bundle phantom. Finally, we provide an example of such an analysis by comparing a clinical patient group to a healthy control group, which demonstrates that all three measures provide distinct and complementary information. By capturing information from both sources, the combined fibre density and cross-section measure is likely to be more sensitive to certain pathologies and more directly interpretable.

1 December 2010 in NeuroImage
Verified
Journal Article
Closed access
JBJosephine Barnes
Josephine Barnes
GRGerard R. Ridgway
Gerard R. Ridgway
JBJonathan Bartlett
Jonathan Bartlett
SHSusie M.D. Henley
Susie M.D. Henley
MLManja Lehmann
Manja Lehmann
NFNick C. Fox
Nick C. Fox

1 January 2015 in NeuroImage
Verified
Journal Article
Open access
IMIan Malone
Ian Malone
KLKelvin K. Leung
Kelvin K. Leung
SCShona Clegg
Shona Clegg
JBJosephine Barnes
Josephine Barnes
JWJennifer L. Whitwell
Jennifer L. Whitwell
GRGerard R. Ridgway
Gerard R. Ridgway
Total intracranial volume (TIV/ICV) is an important covariate for volumetric analyses of the brain and brain regions, especially in the study of neurodegenerative diseases, where it can provide a proxy of maximum pre-morbid brain volume. The gold-standard method is manual delineation of brain scans, but this requires careful work by trained operators. We evaluated Statistical Parametric Mapping 12 (SPM12) automated segmentation for TIV measurement in place of manual segmentation and also compared it with SPM8 and FreeSurfer 5.3.0. For T1-weighted MRI acquired from 288 participants in a multi-centre clinical trial in Alzheimer's disease we find a high correlation between SPM12 TIV and manual TIV (R(2)=0.940, 95% Confidence Interval (0.924, 0.953)), with a small mean difference (SPM12 40.4±35.4ml lower than manual, amounting to 2.8% of the overall mean TIV in the study). The correlation with manual measurements (the key aspect when using TIV as a covariate) for SPM12 was significantly higher (p<0.001) than for either SPM8 (R(2)=0.577 CI (0.500, 0.644)) or FreeSurfer (R(2)=0.801 CI (0.744, 0.843)). These results suggest that SPM12 TIV estimates are an acceptable substitute for labour-intensive manual estimates even in the challenging context of multiple centres and the presence of neurodegenerative pathology. We also briefly discuss some aspects of the statistical modelling approaches to adjust for TIV.